Vibration for Pain Reduction During Trigger Point Injection
Primary Purpose
Myofascial Pain Syndromes
Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Vibration
Placebo vibration
Sponsored by
About this trial
This is an interventional treatment trial for Myofascial Pain Syndromes focused on measuring Myofascial Pain Syndromes, Gastrocnemius, Trigger points, Injections, Vibration
Eligibility Criteria
Inclusion Criteria:
- Patients who have the trigger point in the gastrocnemius and show referred pain.
Exclusion Criteria:
- Those with prior history of trigger point injection
- Those with taking anti-platelet agent
- Those with hemorrhage tendency
- Pregnancy
- Acute infection
- those who were unable to understand a visual analog scale (VAS) or a Likert scale
Sites / Locations
- Soonchunhyang University Hospital, Bucheon
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Vibration group
Placebo group
Arm Description
Vibrator head was applied (100Hz) on the popliteal fossa, during the trigger point injection
In placebo group, vibrator head was applied with switch-off sate, during the trigger point injection
Outcomes
Primary Outcome Measures
Visual analog scale
100 mm visual analog scale for evaluating the pain of trigger point injection
Secondary Outcome Measures
5 point Likert scale for participant satisfaction
5 point Likert scale to answer "Are you satisfied with the vibration application for reducing the pain of trigger point injection?"
5 point Likert scale for repeated usage
5 point Likert scale to answer "Will you use the vibration application again if the trigger point injection is repeated in the future?"
Full Information
NCT ID
NCT03365674
First Posted
December 3, 2017
Last Updated
February 20, 2019
Sponsor
The Catholic University of Korea
Collaborators
Soonchunhyang University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03365674
Brief Title
Vibration for Pain Reduction During Trigger Point Injection
Official Title
Vibration Anesthesia for Pain Reduction During Trigger Point Injection to the Gastrocnemius
Study Type
Interventional
2. Study Status
Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
September 30, 2017 (Actual)
Primary Completion Date
March 30, 2018 (Actual)
Study Completion Date
April 30, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Catholic University of Korea
Collaborators
Soonchunhyang University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to evaluate the effects of vibration anesthesia for reducing pain induced by trigger point injection of gastrocnemius.
Sixty patients were randomized into the vibration or placebo group. In vibration groups, vibrator head was applied (100Hz) on the popliteal fossa, during the trigger point injection. In placebo group, same vibrator head was applied with switch-off sate. Then, a visual analog scale to evaluate the pain of trigger point injection and a five-point Likert scale for patients satisfaction were compared between the two groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myofascial Pain Syndromes
Keywords
Myofascial Pain Syndromes, Gastrocnemius, Trigger points, Injections, Vibration
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Vibration group
Arm Type
Experimental
Arm Description
Vibrator head was applied (100Hz) on the popliteal fossa, during the trigger point injection
Arm Title
Placebo group
Arm Type
Placebo Comparator
Arm Description
In placebo group, vibrator head was applied with switch-off sate, during the trigger point injection
Intervention Type
Device
Intervention Name(s)
Vibration
Intervention Description
Vibration applied with vibrator switch-on state (100Hz)
Intervention Type
Device
Intervention Name(s)
Placebo vibration
Intervention Description
Vibrator applied with switch-off state
Primary Outcome Measure Information:
Title
Visual analog scale
Description
100 mm visual analog scale for evaluating the pain of trigger point injection
Time Frame
Immediately after trigger point injection (within 5 minute)
Secondary Outcome Measure Information:
Title
5 point Likert scale for participant satisfaction
Description
5 point Likert scale to answer "Are you satisfied with the vibration application for reducing the pain of trigger point injection?"
Time Frame
Immediately after trigger point injection (within 5 minute)
Title
5 point Likert scale for repeated usage
Description
5 point Likert scale to answer "Will you use the vibration application again if the trigger point injection is repeated in the future?"
Time Frame
Immediately after trigger point injection (within 5 minute)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who have the trigger point in the gastrocnemius and show referred pain.
Exclusion Criteria:
Those with prior history of trigger point injection
Those with taking anti-platelet agent
Those with hemorrhage tendency
Pregnancy
Acute infection
those who were unable to understand a visual analog scale (VAS) or a Likert scale
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sang-Hyun Kim, MD,PhD
Organizational Affiliation
Soonchunhyang University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Soonchunhyang University Hospital, Bucheon
City
Bucheon-si
State/Province
Gyeonggi-do
ZIP/Postal Code
14584
Country
Korea, Republic of
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
There is not a plan to make IPD available.
Citations:
PubMed Identifier
19651267
Citation
Yoon SH, Rah UW, Sheen SS, Cho KH. Comparison of 3 needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomized controlled trial. Arch Phys Med Rehabil. 2009 Aug;90(8):1332-9. doi: 10.1016/j.apmr.2009.01.028.
Results Reference
background
PubMed Identifier
24464122
Citation
Mally P, Czyz CN, Chan NJ, Wulc AE. Vibration anesthesia for the reduction of pain with facial dermal filler injections. Aesthetic Plast Surg. 2014 Apr;38(2):413-8. doi: 10.1007/s00266-013-0264-4. Epub 2014 Jan 24.
Results Reference
background
PubMed Identifier
28244902
Citation
Park KY, Lee Y, Hong JY, Chung WS, Kim MN, Kim BJ. Vibration Anesthesia for Pain Reduction During Intralesional Steroid Injection for Keloid Treatment. Dermatol Surg. 2017 May;43(5):724-727. doi: 10.1097/DSS.0000000000001040.
Results Reference
background
PubMed Identifier
30926293
Citation
Moon YE, Kim SH, Seok H, Lee SY. Efficacy of Topical Vibratory Stimulation for Reducing Pain During Trigger Point Injection to the Gastrocnemius: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2019 Sep;100(9):1607-1613. doi: 10.1016/j.apmr.2019.02.010. Epub 2019 Mar 27.
Results Reference
derived
Learn more about this trial
Vibration for Pain Reduction During Trigger Point Injection
We'll reach out to this number within 24 hrs